Bionomics

Contact
bionomics.com.au
+18312463642

Bionomics Limited

200 Greenhill Road
5063 Eastwood
Australia
+18312463642
bionomics.com.au
Contact
Profile News
Contact

About Bionomics

Bionomics is a leading international biotechnology company which discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule product development programs in the areas of cancer, anxiety, epilepsy and multiple sclerosis.

Read more about Bionomics
Facts about Bionomics
  • Focus : Laboratory
  • Industry : Pharma

News about Bionomics

Bionomics

23-Apr-2015 | research and development

Bionomics initiates Phase II clinical trial of anxiety treatment

Bionomics Limited announced the initiation of a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety ...

Read news
Bionomics

02-Feb-2015 | research and development

Bionomics begins Phase 1b study with anxiety drug

Bionomics Limited has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the Company’s drug candidate in development for the treatment of ...

Read news
Bionomics

25-Jun-2014 | business & finance

Bionomics and Merck enter new research colloboration

Bionomics Limited announced that it has entered into an exclusive Research Collaboration and License Agreement with Merck, known as MSD outside the United ...

Read news
Bionomics

18-Sep-2012 | business & finance

Bionomics Acquires US-Based Cancer Stem Cell Company Eclipse Therapeutics

Acquisition provides Bionomics with cancer stem cell technology and antibody drug candidates

Read news
Bionomics

24-May-2012 | research and development

Bionomics launches ovarian cancer trial

Bionomics Limited has launched a Phase I/II clinical trial of its vascular disrupting agent BNC105 in women with ovarian cancer.  It is anticipated that up ...

Read news
Bionomics

06-Jan-2012 | business & finance

Ironwood Pharmaceuticals and Bionomics announce collaboration research

Companies to Collaborate on Central Nervous System Disorder Opportunity

Read news
Bionomics

04-Aug-2011 | research and development

Bionomics BNC105 cancer clinical trials reach key milestones

Clinical program to be expanded

Read news
Bionomics

31-Mar-2011 | research and development

Bionomics anti-axiety drug Phase Ib clinical trials deliver successful results

BNC210 significantly reduced panic symptoms and faster than placebo

Read news
Show more news about Bionomics

Here you will find Bionomics Limited